Increased virus replication in mammalian cells by blocking intracellular innate defense responses

Gene Therapy

Volumn 15, Issue 7, 2008, Pages 545-552

  de Vries, W ^a   Haasnoot, J ^a   van der Velden, J ^b   van Montfort, T ^a   Zorgdrager, F ^a   Paxton, W ^a   Cornelissen, M ^a   van Kuppeveld, F ^c   de Haan, P ^b   Berkhout, B ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Phytovation BV Wassenaarseweg   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERFERON; LENTIVIRUS VECTOR; RNA; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INNATE IMMUNITY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SINDBIS VIRUS; VIRUS GENE; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRIDAE; ANIMALS; CATTLE; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HIV-1; HUMANS; IMMUNITY, NATURAL; INTERFERONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-INDUCED SILENCING COMPLEX; SINDBIS VIRUS; TRANSFECTION; VIRAL VACCINES; VIRUS DISEASES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; SINDBIS VIRUS;

EID: 40949160903     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.12     Document Type: Article

References (51)

1. Meylan. E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39-44.
2. Liu YJ. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immnunol 2005; 23:275-306.
3. Uematsu S, Akira S. The role of Toll-like receptors in immune disorders. Expert Opin Biol Ther 2006; 6: 203-214.
4. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui k et al Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and functin. Cell 2004; 116: 281-197.
6. Lee Y, Kim M, Han J, Yeom KH, Lee S, Back SH et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060.
7. Kasschau KD, Carrington JC. A counterdefensive strategy of plant viruses: Suppression of posttranscriptional gene silencing. Cell 1998; 95: 461-470.
8. Segers GC, Zhang X, Deng F, Sun Q, Nuss DL. Evidence that RNA silencing functions as an antiviral defense mechanism in fungi. Proc Natl Acad Sci USA 2007; 104: 12902-12906.
9. Wang XH, Aliyari R, Li WX, Li HW, Kim K, Carthew R et al. RNA interference directs innate immunity against viruses in adult Drosophila. Science 2006; 312: 452-454.
10. Wilkins C, Dishongh R, Moore SC, Whitt MA, Chow M, Machaca K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 2005; 436: 1044-1047.
11. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005; 22 607-619.
12. Bucher E, Hemmes H, de Haan P, Goldbach R, Prins M. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J Gen Virol 2004; 85: 983-991.
13. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 2007; 3: E86.
14. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci USA 2004; 101: 1350-1355.
15. Kao SC, Krichevsky AM, Kosik KS, Tsai, LH. BACE1 suppression by RNA interference in primary cortical neurons. J Biol Chem 2004; 279 1942-1949.
16. Triboulet R, Mari B, Lin YL, Chable-BOssia C, Bennasser Y, Lebrigand K et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315: 1579-1582.
17. Soifer HS, Zaragoza A, Peyvan M, Behlke MA, Rossi JJ. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res 2005; 33: 846-856.
18. Matskevich AA, Moelling K. Dicer is involved in protection against influenza A virus infection. J Gen Virol 2007; 88: 2627-2635.
19. Calabrese JM, Seila AC, Yeo GW, Sharp PA. RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc Natl Acad Sci USA 2007; 104: 18097-18102.
20. Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 2006; 442: 199-202.
21. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
22. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293 834-838.
23. Chu CY, Rana TM. Small RNAs: Regulators and guardians of the genome. J Cell Physiol 2007; 213: 412-419.
24. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
25. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404: 293-296.
26. Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 2001; 107 309-321.
27. Konstantinova P, de Vries W, Haasnoot J, Ter Brake O, de Haan P, Berkhout B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther 2006; 13 1403-1413.
28. Haasnoot PCJ, Cupac D, Berkhout B. Inhibition of virus replication by RNA interference. J Biomed Sci 2003; 10: 607-616,
29. Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: strike and counterstrike. Nat Biotechnol 2007; 25: 1435-1443.
30. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 2000; 97: 12289-12294.
31. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M et al. The Ebola virus VP35 protein inhibits activation of interferon regulatorpy factor 3. J Virol 2003; 77: 7945-7956.
32. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998; 252: 324-330.
33. Cai R, Carpick B, Chun RF, Jeang KT, Williams BR. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 2000; 373: 361-367.
34. McMillan NA, Chun RF, Siderovski DP, Galabru. J, Toone WM, Samuel CE et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 1995; 213 413-424.
35. Lecellier CH, Dunoyer P, Arar k, Lehmann-Che J, Eyquem, S, Himber C et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308: 557-560.
36. Vargason JM, Szittya G, Burgyan J, Tanaka Hall TM. Size selective recognition of siRNA by an RNA silencing suppressor. Cell 2003; 115: 799-811.
37. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M et al. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002; 159: 441-452.
38. Kohn DB. Lentiviral vectors ready for prime-time. Nat Biotechnol 2007; 25: 65-66.
39. Sinn PL, Sauter SL, McCray Jr PB. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Ther 2005; 12: 1089-1098.
40. Goncalves MA, Pau MG, de Vries AA, Valerio D. Generation of a high-capacity hybrid vector: Packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology 2001; 288: 236-246.
41. Lundstrom K. Biology and application of alphaviruses in gene therapy. Gene Ther 2005; 12: S92-S97.
42. Min JY, Krug RM. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci USA 2006; 103 7100-7105.
43. Cardenas WB, Loo YM, Gale Jr M, Hartman AL, Kimberlin CR, Martinez-Sobrido, L et al. Ebola vinis VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 2006; 80: 5168-5178.
44. Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 1997; 16: 611-624.
45. Kok KH, Ng MH, Ching YP, Jin DY. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem 2007; 282: 17649-17657.
46. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J 2006; 25: 522-532.
47. Patel RC, Sen GC. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 1998; 17: 4379-4390.
48. Pedersen, IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-922.
49. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nat Med 2007; 13: 1241-1247.
50. Malathi K, Dong B, Gale Jr M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007; 448 816-819.
51. Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, Lamers WH. Factor correction as a tool to eliminate between-session variation in replicate experiments: Application to molecular biology and retrovirology. Retrovirology 2006; 3: 1-8.